Skip to content

HEW PHARMA: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

HEW PHARMA

BE 0681.590.393
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
financial year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€30,396
2024 · -€87,290+€117,686
Equity
€279,177
2024 · €248,782+€30,396
Cash
€487,751
2024 · €429,384+€58,366
Balance sheet total
€1.0m
2024 · €989,236+€16,823

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€104,359

    down €104,359 (-54.6%), from €191,120 to €86,762

    of which Other amounts receivable: -€118,035

  • Cash +€58,366

    up €58,366 (+13.6%), from €429,384 to €487,751

    mainly Receivables within one year (+€104,359) and Net result for the year (+€30,396)

  • Stocks and contracts +€46,334

    up €46,334 (+15.3%), from €302,373 to €348,707

  • Tangible fixed assets +€16,588

    up €16,588 (+25.2%), from €65,727 to €82,316

    of which Plant, machinery and equipment: +€13,752

Equity and liabilities
  • Trade debts -€36,931

    down €36,931 (-7.3%), from €503,643 to €466,712

  • Profit (loss) carried forward +€30,396

    up €30,396 (+13.2%), from €230,232 to €260,627

  • Other debts +€11,671

    up €11,671 (+47.2%), from €24,711 to €36,382

  • Tax, wage and social debts +€10,412

    up €10,412 (+19.8%), from €52,561 to €62,974

    of which Taxes: +€7,240

Income statement
  • Gross operating margin +€100,416

    up €100,416 (+340.1%), from €29,521 to €129,937

  • Staff costs +€23,518

    up €23,518 (+33.9%), from €69,344 to €92,863

  • Taxes -€14,480

    down €14,480 (-159.6%), from -€9,072 to -€23,552

  • Depreciation +€7,581

    up €7,581 (+39.7%), from €19,077 to €26,658

  • Other operating charges +€4,185

    up €4,185 (+489.1%), from €856 to €5,040

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€87,290
Gross operating margin +€100,416
Staff costs -€23,518
Depreciation -€7,581
Other operating charges -€4,185
Other operating items +€35,550
Financial income +€1
Financial charges +€2,521
Taxes +€14,480
Result 2025 €30,396

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€100,337
Investment -€43,246
Financing +€1,275
Cash 2024 €429,384
Net result for the year +€30,396
Depreciation +€26,658
Stocks and contracts -€46,334
Receivables within one year +€104,359
Deferred charges and accrued income +€107
Trade debts -€36,931
Tax, wage and social debts +€10,412
Other debts +€11,671
Investment in fixed assets (net) -€43,246
Current portion of long-term debt +€1,275
Cash 2025 €487,751
Every line side by side 42 lines
Line Code 2024 2025 Change %
Total assets 20/58 €989,236 €1,006,059 +€16,823 +1.7%
Fixed assets 21/28 €65,727 €82,316 +€16,588 +25.2%
Tangible fixed assets 22/27 €65,727 €82,316 +€16,588 +25.2%
Plant, machinery and equipment 23 €65,405 €79,157 +€13,752 +21.0%
Furniture and vehicles 24 €323 €3,159 +€2,836 +879.4%
Current assets 29/58 €923,509 €923,744 +€235 0.0%
Stocks and contracts in progress 3 €302,373 €348,707 +€46,334 +15.3%
Stocks 30/36 €302,373 €348,707 +€46,334 +15.3%
Amounts receivable within one year 40/41 €191,120 €86,762 -€104,359 -54.6%
Trade receivables 40 €57,674 €71,351 +€13,677 +23.7%
Other amounts receivable 41 €133,446 €15,411 -€118,035 -88.5%
Cash at bank and in hand 54/58 €429,384 €487,751 +€58,366 +13.6%
Deferred charges and accrued income 490/1 €631 €524 -€107 -17.0%
Total equity and liabilities 10/49 €989,236 €1,006,059 +€16,823 +1.7%
Equity 10/15 €248,782 €279,177 +€30,396 +12.2%
Contributions 10/11 €18,550 €18,550 = 0.0%
Profit (loss) carried forward 14 €230,232 €260,627 +€30,396 +13.2%
Amounts payable 17/49 €740,455 €726,882 -€13,573 -1.8%
Amounts payable after more than one year 17 €90,000 €90,000 = 0.0%
Financial debts 170/4 €90,000 €90,000 = 0.0%
Amounts payable within one year 42/48 €650,455 €636,882 -€13,573 -2.1%
Current portion of amounts payable after more than one year 42 €69,539 €70,814 +€1,275 +1.8%
Trade debts 44 €503,643 €466,712 -€36,931 -7.3%
Suppliers 440/4 €503,643 €466,712 -€36,931 -7.3%
Taxes, remuneration and social security 45 €52,561 €62,974 +€10,412 +19.8%
Taxes 450/3 €29,473 €36,713 +€7,240 +24.6%
Remuneration and social security 454/9 €23,088 €26,260 +€3,172 +13.7%
Other amounts payable 47/48 €24,711 €36,382 +€11,671 +47.2%
Remuneration, social security and pensions 62 €69,344 €92,863 +€23,518 +33.9%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €19,077 €26,658 +€7,581 +39.7%
Other operating charges 640/8 €856 €5,040 +€4,185 +489.1%
Non-recurring operating charges 66A €35,550 €0 -€35,550 -100.0%
Gross operating margin 9900 €29,521 €129,937 +€100,416 +340.1%
Operating profit (loss) 9901 -€95,306 €5,377 +€100,682
Financial income 75/76B - €1 +€1
Recurring financial income 75 - €1 +€1
Financial charges 65/66B €1,056 -€1,465 -€2,521
Recurring financial charges 65 €1,056 -€1,465 -€2,521
Profit (loss) for the period before taxes 9903 -€96,362 €6,843 +€103,205
Income taxes 67/77 -€9,072 -€23,552 -€14,480 -159.6%
Profit (loss) for the period 9904 -€87,290 €30,396 +€117,686
Profit (loss) for the period to be appropriated 9905 -€87,290 €30,396 +€117,686

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.